ONO PHARMA USA Revenue and Competitors
Estimated Revenue & Valuation
- ONO PHARMA USA's estimated annual revenue is currently $25.7M per year.
- ONO PHARMA USA's estimated revenue per employee is $201,000
Employee Data
- ONO PHARMA USA has 128 Employees.
- ONO PHARMA USA grew their employee count by 39% last year.
ONO PHARMA USA's People
| Name | Title | Email/Phone |
|---|
ONO PHARMA USA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is ONO PHARMA USA?
ONO PHARMA USA, INC. (OPUS) was established in 1998 as the US subsidiary of Ono Pharmaceutical Co., Ltd. (ONO), an R&D-oriented pharmaceutical company founded in 1717 with headquarters in Osaka, Japan. For more than 300 years ONO has made progress in our commitment to relieve patients' pain, focus on their health improvement and succeed in delivering \First in class\ medicines, such as OPDIVO® (nivolumab), to patients. OPUS is pursuing overseas clinical trials of our new drug candidates and continuously and vigorously promotes licensing activities as a potential means of expanding our development pipeline and globally marketing new drugs that we develop.
keywords:N/A
N/A
Total Funding
128
Number of Employees
$25.7M
Revenue (est)
39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $41.6M | 128 | 1% | N/A |
#2 | $17.9M | 128 | 7% | N/A |
#3 | $25.7M | 128 | 39% | N/A |
#4 | $19.8M | 128 | 22% | N/A |
#5 | $28.4M | 129 | 1% | N/A |